Page last updated: 2024-10-22

acetovanillone and Parkinsonian Disorders

acetovanillone has been researched along with Parkinsonian Disorders in 3 studies

apocynin : An aromatic ketone that is 1-phenylethanone substituted by a hydroxy group at position 4 and a methoxy group at position 3.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research Excerpts

ExcerptRelevanceReference
" Mito-Apo showed excellent brain bioavailability and also markedly attenuated MPTP-induced oxidative markers in the substantia nigra (SN)."1.43Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease. ( Anantharam, V; Brenza, T; Ghosh, A; Harischandra, DS; Jin, H; Joseph, J; Kalyanaraman, B; Kanthasamy, A; Kanthasamy, AG; Langley, MR; Narasimhan, B; Neal, ML, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Philippens, IH1
Wubben, JA1
Finsen, B1
't Hart, BA1
Ghosh, A1
Langley, MR1
Harischandra, DS1
Neal, ML1
Jin, H1
Anantharam, V1
Joseph, J1
Brenza, T1
Narasimhan, B1
Kanthasamy, A1
Kalyanaraman, B1
Kanthasamy, AG1
Kumar, A1
Singh, BK1
Ahmad, I1
Shukla, S1
Patel, DK1
Srivastava, G1
Kumar, V1
Pandey, HP1
Singh, C1

Other Studies

3 other studies available for acetovanillone and Parkinsonian Disorders

ArticleYear
Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2013, Volume: 8, Issue:3

    Topics: Acetophenones; Administration, Oral; Animals; Callithrix; Enzyme Inhibitors; Female; Male; NADPH Oxi

2013
Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016, Volume: 11, Issue:2

    Topics: Acetophenones; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cel

2016
Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.
    Brain research, 2012, Feb-15, Volume: 1438

    Topics: Acetophenones; Acetylcysteine; Animals; Apoptosis; Caspases; CD11b Antigen; Corpus Striatum; Cytochr

2012